The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics.
Oct 9, 2023
0
1
Swiss pharmaceutical giant Novartis said Monday that it had reached a deal to buy US kidney treatment developer Chinook Therapeutics for up to $3.5 billion.
Jun 12, 2023
0
2
The World Health Organization on Thursday warned against "fake news" after Twitter boss Elon Musk tweeted that countries should not "cede authority to WHO" amid negotiations over a new pandemic treaty.
Mar 23, 2023
0
4
US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.
Mar 13, 2023
0
2
Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots.
Nov 1, 2022
0
14
Danish drugmaker Bavarian Nordic, the lone laboratory manufacturing a licensed vaccine against monkeypox, announced Tuesday a revised supply deal with Canada worth up to $470 million.
Sep 20, 2022
0
0
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases over its role in the US opioid epidemic.
Jul 27, 2022
0
2
Moderna and the UK government on Wednesday announced a deal for the US biotech firm to build a cutting-edge centre to develop and produce mRNA vaccines for respiratory diseases, including COVID.
Jun 22, 2022
0
2
